Review article: the histological assessment of disease activity in ulcerative colitis

E-ISSN： 1365-2036|269-2813|8|957-967

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.269-2813, Iss.8, 2015-10, pp. : 957-967

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Review article: the histological assessment of disease activity in ulcerative colitis

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 8, 2015-10 ,pp. : 957-967

John Wiley & Sons Inc

Access to resources Recommend Favorite

Development of interim patient‐reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 10, 2015-11 ,pp. : 1200-1210

John Wiley & Sons Inc

Access to resources Recommend Favorite

Development of interim patient‐reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 269-2813, Iss. 10, 2015-11 ,pp. : 1200-1210

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fecal levels of leukocyte markers reflect disease activity in patients with ulcerative colitis

By Peterson C. G. B. Sangfelt P. Wagner M. Hansson T. Lettesjö H. Carlson M.

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 67, Iss. 8, 2007-01 ,pp. : 810-820

Informa Healthcare

Access to resources Recommend Favorite

Vedolizumab for ulcerative colitis and Crohn's disease

PRESCRIBER, Vol. 26, Iss. 10, 2015-05 ,pp. : 22-24

John Wiley & Sons Inc

Access to resources Recommend Favorite